Friendship
District of Columbia Judicial Nominations Reform Act of 2025
The bill centralizes D.C. judicial nominations with the President, clarifying who appoints judges but reducing local input and raising risks of politicized selections and transitional uncertainty.
Fraud Prevention and Accountability Act
Exchange Rate Accountability Act of 2026
The bill strengthens U.S. tools to block IMF quota increases tied to exchange‑rate manipulation and increases transparency, at the cost of possible diplomatic friction, slower IMF actions, and modest administrative burdens on Treasury and taxpayers.
FAIR ACT
The bill would speed U.S. patient access to foreign‑authorized drugs and trials and reduce duplication for sponsors at the cost of increased reliance on foreign regulators — trading faster availability and lower administrative burden for heightened safety, equity, and cost risks that could shift scrutiny away from U.S.‑specific review.
Stop Identity Fraud and Identity Theft Act of 2026
The bill offers federal funding and NIST-aligned standards to strengthen and standardize state digital ID systems—reducing fraud and improving access for some—while trading off higher taxpayer and state costs, privacy and surveillance risks, potential market concentration, and exclusionary impacts for some immigrant communities.
Homeopathic Drug Product Safety, Quality, and Transparency Act
The bill increases access and regulatory clarity for homeopathic products—benefiting manufacturers, some clinicians, and consumers seeking those products—while substantially reducing federal oversight and legal remedies, which raises safety, consistency, and potential taxpayer‑cost risks.
Independence Investment Fund Act
The bill creates a government-backed investment vehicle to channel new and sustained capital into U.S. critical and emerging technologies (notably biotech) with professional management and faster implementation, but it increases taxpayer financial exposure, reduces procedural safeguards and oversight, and creates compliance and foreign-capital trade-offs for affected firms.
RED TAPE Act
The bill increases transparency and aims to lower short‑term regulatory costs by forcing monetized benefit–cost analysis, but it raises legal uncertainty and risks weakening protections for health, the environment, equity, and long‑term public benefits.
Fairness for Khobar Act of 2025
The bill expands and speeds access to lump-sum payments for previously excluded Beirut and Khobar victims by easing proof requirements and using reserves to pay promptly, but does so at the risk of diverting limited Fund resources and increasing administrative and potential taxpayer costs.
Words Matter Act of 2025
The bill modernizes federal terminology to reduce stigma and clarify regulatory language for people with intellectual disabilities, but it is largely semantic—imposing modest administrative costs and short-term confusion risks while not creating new substantive protections.